Kan, Yansheng
Liu, Yuling
Pan, Jiacheng
Wang, Ruochen
Zhang, Chen-Yu
Zhou, Zhen
Funding for this research was provided by:
the CAMS Innovation Fund for Medical Sciences (No. CIFMS-2021-I2M-5-015)
the National Natural Science Foundation of China (91857000, 32022015)
the "Open Competition to Select the Best Candidates" Key Technology Program for Nucleic Acid Drugs of NTICB (No. 2022HS02008)
Article History
Received: 5 October 2025
Accepted: 15 May 2026
First Online: 29 May 2026
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare no competing interests.